Abstract Background Diversion of injectable medications by healthcare personnel (HCP) is widely recognized as a source of bloodborne pathogen transmission. Drug diversion can also cause bloodstream infections (BSIs) but may not be identified as a transmission source due to the myriad of potential etiologies of bacterial outbreaks in healthcare settings. Here, we describe characteristics of drug diversion-related bacterial outbreaks to inform identification and control. Methods We searched PubMed using the key terms “outbreak” or “cluster” and “diversion” to identify outbreaks reported from 1990-2023. Publication references were reviewed to identify additional reports. We excluded outbreaks outside the US and those caused by non-bacterial pathogens. We compiled patient- and outbreak-level data, including infection type, pathogen, length of stay, healthcare setting, diversion mechanism, and epidemiologic investigation strategies. Results We identified six drug diversion-related bacterial outbreaks published between 1991-2019, involving 80 patients. 93% (n=74) of patients presented with BSIs; 93% (n=74) were identified after surgery or procedure; 24% (n=18) of patients with a BSI had a polymicrobial infection. Median outbreak duration was 119 days (range: 38-288). All outbreaks involved water-associated bacteria (Table) and four outbreaks reported BSI onset within 48 hours of admission for at least one patient. Outbreaks necessitated multiple epidemiologic strategies, including routine approaches (e.g., case-control study [n=4]) and techniques specific to medication tampering (e.g., medication concentration testing [n=4]). At least three patients (range: 3-24) in each outbreak had related isolates by molecular typing or whole genome sequencing. Four outbreaks reported tampering with opioids administered by patient-controlled analgesia (PCA) pumps. Conclusion Certain features of healthcare BSI outbreaks, including involvement of water-associated bacteria, post-surgical populations, or rapid infection onset, should prompt consideration of drug diversion as a potential route of transmission. Multifaceted strategies, including evaluation for medication tampering, are needed to identify outbreaks from drug diversion. Disclosures All Authors: No reported disclosures
Read full abstract